This inventor holds 2 USPTO granted patents and 9 published patent applications and 15 EPO patents. Top assignees: Ascendis Pharma A/s, Ascendis Pharma Oncology Division A/s. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Kennett SprogØe: Innovator in Growth Hormone Applications
Introduction
Kennett SprogØe is an inventor based in Hellerup, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of long-acting growth hormones. Although he currently holds no granted patents, his work is noteworthy for its potential impact on treating various medical conditions.
Latest Patent Applications
Kennett SprogØe has submitted several patent applications that focus on innovative uses of growth hormones. One of his latest applications is titled "Use Of Long-Acting Growth Hormone For Treating Inflammation-Induced Diseases." This invention relates to a long-acting growth hormone for use in the treatment of inflammation-induced diseases. Another application is "Long-Acting Growth Hormone Dosage Forms With Superior Efficacy to Daily Somatropin." This invention pertains to a long-acting growth hormone or a pharmaceutical formulation comprising such long-acting growth hormone for treating growth hormone deficiency with improved outcomes.
Conclusion
Kennett SprogØe's work in the field of growth hormone applications showcases his innovative spirit and dedication to advancing medical treatments. His latest patent applications reflect a commitment to addressing significant health challenges through scientific research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile